SummaryA new study shows stimulant prescriptions for ADHD in Ontario rose more than 150 percent from 2015 to 2023, with the sharpest increases among women. Researchers say better awareness and easier access to diagnosis are driving the trend, though concerns about misdiagnosis remain as prescriptions climbed rapidly during and after the pandemic.